Author:
Zernig Gerald,Hiemke Christoph
Publisher
Springer International Publishing
Reference37 articles.
1. Bauer LA. Applied clinical pharmacokinetics. New York: McGraw Hill; 2008.
2. Beasley CM Jr, Sanger T, Satterlee W, Tollefson G, Tran P, Hamilton S. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology. 1996a;124:159–67.
3. Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S. Olanzapine versus placebo and haloperidol: acute phase results of the north American double-blind olanzapine trial. Neuropsychopharmacology. 1996b;14:111–23.
4. Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman and Gilman’s the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill; 2017.
5. Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet. 1999;37:177–93.